Skip to main content
. 2008 May 1;5(4):393–405. doi: 10.1513/pats.200801-013ET

TABLE 2.

IMPROVEMENT IN EXERCISE CAPACITY AND HEALTH-RELATED QUALITY OF LIFE AT 24 MONTHS

Improvement in Exercise Capacity, n/total n (%)*
Improvement in Health-related Quality of Life, n/total n (%)*
Patients Surgery Group Medical Therapy Group Odds Ratio P Value Surgery Group Medical Therapy Group Odds Ratio P Value
All patients 54/371 (15) 10/378 (3) 6.27 <0.001 121/371 (33) 34/378 (9) 4.90 <0.001
 High risk 4/58 (7) 1/48 (2) 3.48 0.37 6/58 (10) 0/48 0.03
 Other 50/313 (16) 9/330 (3) 6.78 <0.001 115/313 (37) 34/330 (10) 5.06 <0.001
Subgroups
 Predominantly upper lobe emphysema
  Low exercise capacity 25/84 (30) 0/92 <0.001 40/84 (48) 9/92 (10) 8.38 <0.001
  High exercise capacity 17/115 (15) 4/138 (3) 5.81 0.001 47/115 (41) 15/138 (11) 5.67 <0.001
 Predominantly non–upper lobe emphysema
  Low exercise capacity 6/49 (12) 3/41 (7) 1.77 0.50 18/49 (37) 3/41 (7) 7.35 0.001
  High exercise capacity 2/65 (3) 2/59 (3) 0.90 1.00 10/65 (15) 7/59 (12) 1.35 0.61

Reprinted by permission from Reference 1.

*

Improvement in exercise capacity in patients followed for 24 months after randomization was defined as an increase in the maximal workload of more than 10 W from the patient's post–rehabilitation baseline value. Improvement in the health-related quality of life in patients followed for 24 months after randomization was defined as a decrease in the score on the St. George's Respiratory Questionnaire of more than 5 points (on a 100-point scale) from the patient's post–rehabilitation baseline score. For both analyses, patients who died or who missed the 24-month assessment were considered not to have improvement. Odds ratios are for improvement in the surgery group as compared with the medical therapy group. P values were calculated by Fisher's exact test. A low baseline exercise capacity was defined as a post–rehabilitation baseline maximal workload at or below the sex-specific 40th percentile (25 W for women and 40 W for men); a high exercise capacity was defined as a workload above this threshold.

High-risk patients were defined as those with an FEV1 that was 20% or less of the predicted value and either homogeneous emphysema on computed tomography or a DlCO that was 20% or less of the predicted value.

High-risk patients were excluded from the subgroup analyses. For improvement in exercise capacity, P for interaction = 0.005; for improvement in health-related quality of life, P for interaction = 0.03. These P values were derived from binary logistic-regression models with terms for treatment, subgroup, and the interaction between the two, with the use of an exact-score test with 3 degrees of freedom. Other factors that were considered as potential variables for the definition of subgroups included the baseline FEV1, DlCO, partial pressure of arterial CO2, residual volume, ratio of residual volume to total lung capacity, ratio of expired ventilation in 1 minute to CO2 excretion in 1 minute, distribution of emphysema (heterogeneous vs. homogeneous), perfusion ratio, score for health-related quality of life and Quality of Well-Being score, age, race or ethnic group, and sex.